Request for SCCS scientific opinion on Hexyl Salicylate
Ingredients: HEXYL SALICYLATE

The European Commission has requested the Scientific Committee on Consumer Safety (SCCS) to assess the safety of Hexyl Salicylate as used in cosmetic products.

Background

Hexyl Salicylate (CAS No. 6259-76-3) is an ingredient with sweet, floral, and fruity odour used in formulations of fragrances in multiple consumer goods including cosmetic, household cleaning products,
and detergents.

Currently, Hexyl Salicylate is not listed in the Annexes to the Cosmetic Regulation (EC) No. 1223/2009
and its use is not otherwise restricted in cosmetic products.

The European Risk Assessment Committee (RAC) of the European Chemicals Agency (ECHA) issued in March 2022 an opinion recommending a ‘Toxic for Reproduction Category 2’ (i.e., suspected of damaging the unborn child) and ‘Skin sensitizer Category 1’ classification for Hexyl Salicylate, based on the results of an LLNA assay and on ‘read across’ from the structural analogue Methyl Salicylate and the metabolite Salicylic Acid, respectively.

What’s new?

Following the RAC opinion, it is expected that the European Commission will propose a classification for Hexyl Salicylate as a ‘Toxic for Reproduction Category 2’ and ‘Skin sensitizer Category 1’, updating the Annex VI of CLP Regulation.
However, in December 2022, stakeholders submitted a dossier to support the safe use of Hexyl Salicylate within specific concentration limits for various products types.

On the basis of this dossier, the Commission requests the SCCS to carry out a safety assessment on Hexyl Salicylate in view of the information provided and considering the following questions to be addressed:

1. In light of the data provided and taking under consideration the CMR Cat.2 classification (to be introduced in Annex VI to Reg. 1272/2008), does the SCCS consider Hexyl Salicylate safe when used up to the maximum concentrations provided in the dossier?

This image has an empty alt attribute; its file name is Screenshot-2023-03-14-at-00.00.25-1024x369.png

2. Does the SCCS have any further scientific concerns with regard to the use of Hexyl Salicylate in cosmetic products?

The SCCS approved this mandate by written procedure on 13 February 2023, and the Committee has now 9 months to deliver its Opinion.

References:

1. Scientific Committee on Consumer Safety (SCCS) – Mandates

other
REGULATORY UPDATES

Regulation (EU) 2022/692 – OMNIBUS ACT VI – New and Updated Classification of Cosmetic Ingredients

Ingredients: BENZOPHENONE, TEOPHYLLINE, MELAMINE, AZADIRACHTA EXTRACTS, TRIMETHYLOLPROPANE TRIACRYLATE, PENTETIC ACID, PENTASODIUM PENTETATE

Date of publication: 03/05/2022

Date of application: 01/12/2023

The Commission Delegated Regulation (EU) 2022/692 includes new or updated classification for 12 chemicals that may be used as cosmetic ingredients. Seven out of these 12 are now classified as carcinogenic, mutagenic or toxic to reproduction (CMR) and are banned from cosmetic products marketed in the EU.

Read More »

SCCS Revision of the Scientific Opinion on Vitamin A

Ingredients: RETINOL, RETINYL PALMITATE, RETINYL ACETATE, RETINYL LINOLEATE, RETINAL

Date of publication: 25/10/2022

The Scientific Committee on Consumer Safety has issued a final version of the Scientific Opinion on Vitamin A, concluding that exposure to Vitamin A derived from cosmetics can be a concern for higher exposure consumers, and since cosmetics alone do not exceed the upper limit the SCCS cannot suggest maximum concentration limits that take into account contributions from other sources.

Read More »

Regulation (EU) 2022/1531 – OMNIBUS ACT V – applicable as of 17 December 2022

Ingredients: METHYL SALICYLATE, SODIUM HYDROXYMETHYLGLYCINATE, DBMC, MIBK

Date of publication: 15/09/2022

Date of application: 17/12/2022

The European Commission has published the Commission Regulation (EU) 2022/1531, which amends the Regulation (EC) No 1223/2009 as regards the use in cosmetic products of certain substances classified as CMR, by adding new entries to Annex II and Annex III and revising an entry in Annex V.

Read More »
Any REGULATORY QUESTION?